Cresco Labs (CRLBF) EBT (2020 - 2026)

Cresco Labs' EBT history runs 7 years deep, the most recent figure standing at -$2.8 million for Q1 2026.

• Quarterly EBT fell 204.36% year-over-year to -$2.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$97.3 million (down 254.04% YoY) and the FY2025 annual result came in at -$95.4 million, down 798.85% from the prior year.
• EBT was -$2.8 million for Q1 2026 at Cresco Labs, up from -$87.1 million in the prior quarter.
• Across five years, EBT topped out at $15.9 million in Q1 2024 and bottomed at -$156.9 million in Q4 2022.
• A 5-year average of -$22.5 million and a median of -$918000.0 in 2025 frame the typical range for EBT.
• Annual changes were most pronounced in 2024 — EBT soared 244.94% — and 2025, when it slumped 2952.54%.
• Cresco Labs' EBT stood at -$156.9 million in 2022, then surged by 108.17% to $12.8 million in 2023, then sank by 76.17% to $3.1 million in 2024, then slumped by 2952.54% to -$87.1 million in 2025, then surged by 96.79% to -$2.8 million in 2026.
• Business Quant data shows CRLBF's EBT at -$2.8 million in Q1 2026, -$87.1 million in Q4 2025, and -$10.1 million in Q3 2025.